Walter vonBebenburg, Deceased

Title: Walter von Bebenburg: A Pioneer in Antiepileptic Compounds

Introduction

Walter von Bebenburg was a notable inventor known for his contributions to the field of pharmaceuticals. He was based in Dreieich, Germany, and his work has had a lasting impact on the development of antiepileptic medications. His innovative approach to chemical compounds has paved the way for advancements in treating epilepsy.

Latest Patents

Walter von Bebenburg held a patent for a compound described as 2-Amino-3-acylamino-6-benzylamino-pyridine-derivative. This compound features a formula where R is a C1-C4 alkyl group, a C1-C4 alkoxy group, a phenoxy group, or a phenyl-C1-C2-alkoxy group. The patent also specifies that R1 can be hydrogen or a C1-C4-alkyl group, while R5 can be hydrogen or a C1-C4-alkyl group. The groups R2, R3, and R4 can vary and include hydrogen, halogen atoms, C1-C4 alkyl groups, C1-C4-alkylcarbonyl groups, the aminosulfonyl group, and the trifluoromethyl group. These compounds and their acid addition salts have been recognized for their effectiveness as antiepileptics.

Career Highlights

Walter von Bebenburg's career was marked by his association with Degussa Aktiengesellschaft, a prominent company in the chemical industry. His work there allowed him to focus on the development of innovative pharmaceutical compounds. His dedication to research and development has contributed significantly to the field.

Collaborations

Throughout his career, Walter collaborated with notable colleagues such as Joachim Heese and Jurgen Engel. These collaborations fostered an environment of innovation and creativity, leading to significant advancements in their respective fields.

Conclusion

Walter von Bebenburg's contributions to the pharmaceutical industry, particularly in the development of antiepileptic compounds, have left a lasting legacy. His innovative spirit and dedication to research continue to inspire future generations of inventors and researchers.